BD (NYSE: BDX) shares dipped slightly before hours today on fourth-quarter results that came in mixed compared to the ...

The panels employ PCR techniques to test for numerous gastrointestinal bacterial pathogens using one stool swab.

BD Diagnostics, a segment of Becton, Dickinson and Co., has announced it received FDA clearance to market a new MRSA test, according to a news release. BD received clearance for the BD MAX MRSA ...

Becton Dickinson’s stock narrative has shifted slightly, with the Fair Value Estimate declining modestly from $208 to ...

BD is expanding its long-running partnership with the blood collection company Babson Diagnostics, which aims to make taking a high-quality sample in pharmacies, grocery stores or at home as easy as ...

BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...

Firms’ technologies will be coupled and optimized for pathogen identification. BD Diagnostics and Bruker Daltonics are teaming up to provide an integrated approach to bacterial and fungal ...

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX™ GBS ...

New capillary blood collection device combined with innovative sample handling and analytical technologies in clinical studies aim to make diagnostic blood testing more accessible and convenient ...

Focus is on tests for Europe to detect infections in transplant patients. BD Diagnostics and Biodiversity will work together on a molecular diagnostic menu for immunocompromised patients based on on ...

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) has announced that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging ...